Invesco’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $883M | Buy |
|
|||||
|
2025
Q1 | $895M | Sell |
|
|||||
|
2024
Q4 | $765M | Sell |
|
|||||
|
2024
Q3 | $904M | Buy |
|
|||||
|
2024
Q2 | $845M | Sell |
|
|||||
|
2024
Q1 | $874M | Sell |
|
|||||
|
2023
Q4 | $912M | Buy |
|
|||||
|
2023
Q3 | $701M | Buy |
|
|||||
|
2023
Q2 | $686M | Buy |
|
|||||
|
2023
Q1 | $586M | Buy |
|
|||||
|
2022
Q4 | $469M | Buy |
|
|||||
|
2022
Q3 | $382M | Buy |
|
|||||
|
2022
Q2 | $316M | Sell |
|
|||||
|
2022
Q1 | $316M | Buy |
|
|||||
|
2021
Q4 | $246M | Sell |
|
|||||
|
2021
Q3 | $220M | Buy |
|
|||||
|
2021
Q2 | $235M | Buy |
|
|||||
|
2021
Q1 | $208M | Sell |
|
|||||
|
2020
Q4 | $259M | Sell |
|
|||||
|
2020
Q3 | $308M | Buy |
|
|||||
|
2020
Q2 | $325M | Sell |
|
|||||
|
2020
Q1 | $310M | Buy |
|
|||||
|
2019
Q4 | $240M | Sell |
|
|||||
|
2019
Q3 | $620M | Sell |
|
|||||
|
2019
Q2 | $745M | Buy |
|
|||||
|
2019
Q1 | $686M | Buy |
|
|||||
|
2018
Q4 | $614M | Sell |
|
|||||
|
2018
Q3 | $717M | Sell |
|
|||||
|
2018
Q2 | $645M | Buy |
|
|||||
|
2018
Q1 | $534M | Buy |
|
|||||
|
2017
Q4 | $466M | Buy |
|
|||||
|
2017
Q3 | $471M | Sell |
|
|||||
|
2017
Q2 | $420M | Buy |
|
|||||
|
2017
Q1 | $321M | Buy |
|
|||||
|
2016
Q4 | $214M | Sell |
|
|||||
|
2016
Q3 | $267M | Sell |
|
|||||
|
2016
Q2 | $264M | Sell |
|
|||||
|
2016
Q1 | $264M | Sell |
|
|||||
|
2015
Q4 | $535M | Buy |
|
|||||
|
2015
Q3 | $426M | Buy |
|
|||||
|
2015
Q2 | $463M | Buy |
|
|||||
|
2015
Q1 | $415M | Buy |
|
|||||
|
2014
Q4 | $367M | Buy |
|
|||||
|
2014
Q3 | $320M | Sell |
|
|||||
|
2014
Q2 | $285M | Sell |
|
|||||
|
2014
Q1 | $224M | Sell |
|
|||||
|
2013
Q4 | $242M | Buy |
|
|||||
|
2013
Q3 | $235M | Buy |
|
|||||
|
2013
Q2 | $230M | Buy |
|